Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
346 questions in 59 reviews · Vascular
current versionsNo studies 346 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Transverse groin incision vs vertical groin incision Infection of the vascular graft (endoprosthesis /prosthesis) (early, ≤ 4 months; late, > 4 months) · patients undergoing surgery with femoral artery approach Transverse versus vertical groin incision for femoral artery approach (2020) · Cochrane | no estimate extracted | NR | No studies |
Transverse groin incision vs vertical groin incision Prolonged hospitalization (> 1 week) · patients undergoing surgery with femoral artery approach Transverse versus vertical groin incision for femoral artery approach (2020) · Cochrane | no estimate extracted | NR | No studies |
Transverse groin incision vs vertical groin incision Reoperative surgery (≤ 30 days; > 30 days) · patients undergoing surgery with femoral artery approach Transverse versus vertical groin incision for femoral artery approach (2020) · Cochrane | no estimate extracted | NR | No studies |
Transverse groin incision vs vertical groin incision Death · patients undergoing surgery with femoral artery approach Transverse versus vertical groin incision for femoral artery approach (2020) · Cochrane | no estimate extracted | NR | No studies |
Transverse groin incision vs vertical groin incision Neurological deficit (e.g. paresthesia) · patients undergoing surgery with femoral artery approach Transverse versus vertical groin incision for femoral artery approach (2020) · Cochrane | no estimate extracted | NR | No studies |
Anticoagulation for three months or more vs anticoagulation Overall mortality · people with distal DVT Treatment of distal deep vein thrombosis (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Adverse effects ( · adults with PTS Compression therapy for treating post‐thrombotic syndrome (2019) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Patient satisfaction and quality of life · adults with PTS Compression therapy for treating post‐thrombotic syndrome (2019) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Compliance rate · adults with PTS Compression therapy for treating post‐thrombotic syndrome (2019) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Compliance rate · adults with PTS Compression therapy for treating post‐thrombotic syndrome (2019) · Cochrane | no estimate extracted | NR | No studies |
TNF‐α blockers intervention vs placebo or additional treatment Adverse effects after treatment initiation: injection site reactions, neutropenia, infections, demyelinating disease, heart failure, malignancy, and induction of autoimmunity. · children with Kawasaki disease TNF‐α blockers for the treatment of Kawasaki disease in children (2019) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Proximal DVT · Patients hospitalised following acute myocardial infarction Graduated compression stockings for prevention of deep vein thrombosis (2018) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Pulmonary embolism · Patients hospitalised following acute myocardial infarction Graduated compression stockings for prevention of deep vein thrombosis (2018) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Adverse effects and complications · Patients hospitalised following acute myocardial infarction Graduated compression stockings for prevention of deep vein thrombosis (2018) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Adverse effects and complications · Hospitalised patients1 Graduated compression stockings for prevention of deep vein thrombosis (2018) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Adverse effects and complications · Patients hospitalised for surgical procedures1 Graduated compression stockings for prevention of deep vein thrombosis (2018) · Cochrane | no estimate extracted | NR | No studies |
Externally supported graft vs unsupported graft Primary patency (60 months) · people with peripheral vascular disease requiring above‐knee femoro‐popliteal bypass surgery Graft type for femoro‐popliteal bypass surgery (2018) · Cochrane | no estimate extracted | NR | No studies |
Externally supported graft vs unsupported graft Limb salvage · people with peripheral vascular disease requiring above‐knee femoro‐popliteal bypass surgery Graft type for femoro‐popliteal bypass surgery (2018) · Cochrane | no estimate extracted | NR | No studies |
PTFE vs PTFE with vein cuff Primary patency (60 months) · people with peripheral vascular disease requiring below‐knee femoro‐popliteal bypass surgery Graft type for femoro‐popliteal bypass surgery (2018) · Cochrane | no estimate extracted | NR | No studies |
Autologous vein vs other graft types Limb salvage · people with peripheral vascular disease requiring above‐knee femoro‐popliteal bypass surgery Graft type for femoro‐popliteal bypass surgery (2018) · Cochrane | no estimate extracted | NR | No studies |
Treatment of DVT at home vs treatment Venous gangrene · people with diagnosed DVT Home versus in‐patient treatment for deep vein thrombosis (2018) · Cochrane | no estimate extracted | NR | No studies |
Prophylactic LMWH vs placebo Mortality · people with ST of the leg Treatment for superficial thrombophlebitis of the leg (2018) · Cochrane | no estimate extracted | NR | No studies |
Prophylactic LMWH vs placebo Minor bleeding · people with ST of the leg Treatment for superficial thrombophlebitis of the leg (2018) · Cochrane | no estimate extracted | NR | No studies |
Prophylactic LMWH vs placebo Adverse effects of treatment · people with ST of the leg Treatment for superficial thrombophlebitis of the leg (2018) · Cochrane | no estimate extracted | NR | No studies |
Therapeutic LMWH vs placebo Mortality · people with ST of the leg Treatment for superficial thrombophlebitis of the leg (2018) · Cochrane | no estimate extracted | NR | No studies |
Therapeutic LMWH vs placebo Minor bleeding · people with ST of the leg Treatment for superficial thrombophlebitis of the leg (2018) · Cochrane | no estimate extracted | NR | No studies |
Therapeutic LMWH vs placebo Adverse effects of treatment · people with ST of the leg Treatment for superficial thrombophlebitis of the leg (2018) · Cochrane | no estimate extracted | NR | No studies |
NSAIDs vs placebo Mortality · people with superficial thrombophlebitis of the leg Treatment for superficial thrombophlebitis of the leg (2018) · Cochrane | no estimate extracted | NR | No studies |
NSAIDs vs placebo Minor bleeding · people with superficial thrombophlebitis of the leg Treatment for superficial thrombophlebitis of the leg (2018) · Cochrane | no estimate extracted | NR | No studies |
NSAIDs vs placebo Adverse effects of treatment · people with superficial thrombophlebitis of the leg Treatment for superficial thrombophlebitis of the leg (2018) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Adverse effects (1 day) · adults over the age of 50 with a unilateral transfemoral amputation Prosthetic rehabilitation for older dysvascular people following a unilateral transfemoral amputation (2018) · Cochrane | no estimate extracted | NR | No studies |
Rutosides vs placebo (or no treatment) Occurrence of leg ulceration · patients with PTS Rutosides for treatment of post‐thrombotic syndrome (2018) · Cochrane | no estimate extracted | NR | No studies |
Rutosides vs an alternative venoactive remedy (hidrosmina) Adverse effects · patients with PTS Rutosides for treatment of post‐thrombotic syndrome (2018) · Cochrane | no estimate extracted | NR | No studies |
Rutosides vs placebo (or no treatment) Adverse effects (8 weeks ‐ 12 months) · patients with PTS Rutosides for treatment of post‐thrombotic syndrome (2018) · Cochrane | no estimate extracted | NR | No studies |
Rutosides vs elastic compression stockings Occurrence of leg ulceration · patients with PTS Rutosides for treatment of post‐thrombotic syndrome (2018) · Cochrane | no estimate extracted | NR | No studies |
Rutosides vs elastic compression stockings Adverse effects (12 months) · patients with PTS Rutosides for treatment of post‐thrombotic syndrome (2018) · Cochrane | no estimate extracted | NR | No studies |
Rutosides vs an alternative venoactive remedy (hidrosmina) Occurrence of leg ulceration · patients with PTS Rutosides for treatment of post‐thrombotic syndrome (2018) · Cochrane | no estimate extracted | NR | No studies |
Prostanoids vs naftidrofuryl Cardiovascular mortality · people with critical limb ischaemia Prostanoids for critical limb ischaemia (2018) · Cochrane | no estimate extracted | NR | No studies |
Prostanoids vs naftidrofuryl Quality of life · people with critical limb ischaemia Prostanoids for critical limb ischaemia (2018) · Cochrane | no estimate extracted | NR | No studies |
PGE1 vs ATP Cardiovascular mortality · people with critical limb ischaemia Prostanoids for critical limb ischaemia (2018) · Cochrane | no estimate extracted | NR | No studies |
PGE1 vs ATP Quality of life · people with critical limb ischaemia Prostanoids for critical limb ischaemia (2018) · Cochrane | no estimate extracted | NR | No studies |
PGE1 vs inositol niacinate Cardiovascular mortality · people with critical limb ischaemia Prostanoids for critical limb ischaemia (2018) · Cochrane | no estimate extracted | NR | No studies |
PGE1 vs inositol niacinate Total amputations · people with critical limb ischaemia Prostanoids for critical limb ischaemia (2018) · Cochrane | no estimate extracted | NR | No studies |
PGE1 vs inositol niacinate Quality of life · people with critical limb ischaemia Prostanoids for critical limb ischaemia (2018) · Cochrane | no estimate extracted | NR | No studies |
Prostanoids vs placebo Quality of life · people with critical limb ischaemia Prostanoids for critical limb ischaemia (2018) · Cochrane | no estimate extracted | NR | No studies |
Iloprost vs PGE1 Cardiovascular mortality · people with critical limb ischaemia Prostanoids for critical limb ischaemia (2018) · Cochrane | no estimate extracted | NR | No studies |
Iloprost vs PGE1 Quality of life · people with critical limb ischaemia Prostanoids for critical limb ischaemia (2018) · Cochrane | no estimate extracted | NR | No studies |
Clinprost vs lipo‐PGE1 Total amputations · people with critical limb ischaemia Prostanoids for critical limb ischaemia (2018) · Cochrane | no estimate extracted | NR | No studies |
Clinprost vs lipo‐PGE1 Quality of life · people with critical limb ischaemia Prostanoids for critical limb ischaemia (2018) · Cochrane | no estimate extracted | NR | No studies |
Prostanoids vs pentoxifylline Cardiovascular mortality · people with critical limb ischaemia Prostanoids for critical limb ischaemia (2018) · Cochrane | no estimate extracted | NR | No studies |